Zhejiang Adolescent Spine and Vision Health Cohort: A Longitudinal Database Analysis
NCT ID: NCT06992622
Last Updated: 2025-05-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
73000 participants
OBSERVATIONAL
2024-09-30
2032-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
2.To track 8-year dynamic changes in spinal curvature and analyze associations between scoliosis, vision disorders, and potential risk factors.
3.To deliver scoliosis health education during screenings.
4.To mitigate scoliosis progression through early detection and intervention.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Non-Pharmacological Treatment of Vestibular Migraine in Children and Adolescent
NCT05914207
Optic Neuritis Differential Diagnosis Study
NCT03370965
Observation Versus Occlusion Therapy for Intermittent Exotropia
NCT01032330
Evaluation of Visual - Motor Development in Children With Retinopathy of Prematurity
NCT03865134
Combining Donepezil With Perceptual Learning in Normal and Amblyopic Human The Effect of Donepezil on Perceptual Learning in Adult Amblyopia
NCT03109314
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Despite extensive research exploring potential causes - including genetic, neuroendocrine, skeletal, muscular, postural, biomechanical and lifestyle factors - the underlying mechanisms of IS remain unclear. Bracing currently stands as the only proven conservative treatment to slow progression, yet 20-30% of braced patients still require eventual surgical correction. Adolescence represents both a critical window for rapid curve progression and the optimal period for effective intervention. Early screening has been demonstrated to significantly improve outcomes, highlighting the importance of preventive strategies during this developmental stage.
Recent studies across various populations have reported scoliosis prevalence rates ranging from 0.27% to 3.5%, with notable regional variations:
Singaporean studies found rates between 0.27%-2.49%
Greek research reported 1.7% prevalence
Large-scale US screening showed 0.9% prevalence
Chinese studies documented rates from 1.07% (Guangzhou) to 3.5% (Hong Kong)
Most existing research has been cross-sectional in design, lacking prospective data on curve progression patterns and associated risk factors.
This prospective cohort study aims to:1. To investigate the prevalence of scoliosis, other spinal deformities, myopia, and visual impairments in adolescents (aged 6-18) in Zhejiang Province.
2.To track 8-year dynamic changes in spinal curvature and analyze associations between scoliosis, vision disorders, and potential risk factors.
3.To deliver scoliosis health education during screenings.
4.To mitigate scoliosis progression through early detection and intervention.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
IS with Myopia
diopathic scoliosis with untreated myopia
No interventions assigned to this group
IS without Myopia
diopathic scoliosis without myopia
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Skeletally immature (Risser Sign 0-3)
* Cobb angle between 11-40 degrees
* Age between 6 and 17
Exclusion Criteria
* History of previous spine surgery or spinal injury
* Tumor or malignant tumor in the spine
* Leg length discrepancy more than 20 mm
* Previous diagnosis or treatment of SDB more than 6 months ago
* Plans to relocate within the next 24 months
6 Years
17 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Second Affiliated Hospital of Wenzhou Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Xiangyang Wang
M.D., Chief physician, Doctorial supervisor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Xiangyang Wang
Role: STUDY_CHAIR
Second Affiliated Hospital of Wenzhou Medical University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325000
Wenzhou, Zhejiang, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SAHoWMU-CR2025-08-220
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.